Delivery Order SPE2DB20D2104-SPE2DB24FQ68Y
Award Date
10/11/23
Potential Completion Date
10/12/23
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1200|SPE2DB24FN1QK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,104.00 firm fixed price delivery order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on an...
This federal contract award, with ID SPE2DB20D2014|SPE2DB24FB41M, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,312.28 firm fixed price delivery order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a performance period through March 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL7RN, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with an ultimate completion date of February 4, 2025 and a ceiling value of $14,710.05. This is a firm-fixed-price delivery order contract. The award is not associated with a set-aside designation, indicating open competition....
This federal contract award, with a maximum ceiling value of $3,979.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of July 31, 2024. This is a firm-fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and...
This federal contract award, identified as SPE2DB20D3101|SPE2DB24FRPE1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,840.11, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of July 3, 2024. The contract is not designated as a set-aside, indicating open...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FU70C, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,619.84 contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of August 4, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award SPE2DB20D3303|SPE2DB25FY8F1, with a ceiling value of $2,992.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product, to support federal healthcare programs. The contract is a delivery order and has a firm fixed price pricing type. It does not have a set-aside designation, indicating...
This federal contract award, with ID SPE2DB20D3104|SPE2DB23FV6M6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,697.60, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 3, 2023. It is not designated with any set-aside...
This federal contract award, with an ID of SPE2DB20D1051|SPE2DB25FD7KQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $4,312.03 firm fixed-price delivery order is for MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $3,156.00 with an ultimate completion date of August 9, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). The contract covers the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is not associated with a set-aside program and...